Home/Filings/4/0001126234-14-000060
4//SEC Filing

NEWLINK GENETICS CORP 4

Accession 0001126234-14-000060

CIK 0001126234operating

Filed

Feb 5, 7:00 PM ET

Accepted

Feb 6, 4:36 PM ET

Size

11.0 KB

Accession

0001126234-14-000060

Insider Transaction Report

Form 4
Period: 2014-02-04
LINK GORDON H JR
Chief Financial Officer
Transactions
  • Sale

    Common Stock

    2014-02-04$36.74/sh400$14,69616,413 total
  • Sale

    Common Stock

    2014-02-04$37.44/sh100$3,74416,313 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2014-02-0450064,739 total
    Exercise: $2.10Exp: 2018-08-05Common Stock (500 underlying)
  • Exercise/Conversion

    Common Stock

    2014-02-04$2.10/sh+500$1,05016,813 total
Footnotes (5)
  • [F1]Includes 5,700 restricted stock units ("RSUs") previously reported as holdings of the Reporting Person granted under the Issuer's 2009 Equity Incentive Plan (the "Plan"). The RSUs will vest, and shares will be delivered to the Reporting Person in a series of four successive annual installments beginning on January 2, 2015, provided in each case that the Reporting Person's continuous service to the Issuer has not been terminated as defined in or as determined under the Plan.
  • [F2]Includes 2,100 shares acquired under the NewLink Genetics Corporation 2010 Employee Stock Purchase Plan on June 28, 2013.
  • [F3]The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on 7/29/2013.
  • [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.05 to $37.02, inclusive. The reporting person undertakes to provide to the issuer, any security holder of issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote to this Form 4.
  • [F5]1/4th of the shares vest on August 4, 2009, which is one year after the vesting commencement date. 1/48th of the shares vest monthly thereafter over the next three years.

Issuer

NEWLINK GENETICS CORP

CIK 0001126234

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001126234

Filing Metadata

Form type
4
Filed
Feb 5, 7:00 PM ET
Accepted
Feb 6, 4:36 PM ET
Size
11.0 KB